Modeling of Hantavirus Reservoirs in Brazil
巴西汉坦病毒库建模
基本信息
- 批准号:7559564
- 负责人:
- 金额:$ 3.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-20 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesApplications GrantsAreaBiodiversityBiological AssayBloodBrazilCellsClinicalDataDatabasesDiagnosisDiseaseEcologyEcosystemEnvironmentGrantHabitatsHantavirusHantavirus InfectionsHealthHumanIncidenceIndividualInfectionInformation SystemsInvestigationLatin AmericaLifeLocationLongitudinal StudiesMapsMethodsModelingMonitorMovementNeutralization TestsParaguayParentsPatientsPhylogenetic AnalysisPhysiciansPopulationPrevalenceProceduresPropertyPublic HealthReportingReproductionReproductive HistoryResearchResearch PersonnelResearch TrainingRodentSamplingScientistSeriesSiteSpecimenTechnology TransferTestingTimeTrainingVirusVisitWorkanthropogenesisbasebiosafety level 3 facilityexperienceforesthuman diseaseland covermultidisciplinarytransmission processviral RNA
项目摘要
DESCRIPTION (provided by applicant): The parent R01 grant for this proposal, "Land Cover Change in the Chaco and Interior Atlantic Forest (IAF) in Paraguay on Hantavirus Ecology " is testing the hypothesis that the rapid anthropogenic land cover change occurring in Paraguay will have a direct impact of ecosystem viability and biodiversity, and therefore, will affect rodent-hantavirus ecology. From 2003 to present, Brazil has reported 670 cases. In the Brazilian Department, where we propose the research to take place, there were 40 cases (Pincelli et al., 2003). Extension of this project to Brazil will build several important capacities. They include: 1. Approaches and methods in geospatial model building. 2. Approaches and methods in capturing rodents and taking samples from rodents which may harbor possible serious human diseases. 3. Approaches and methods toward general daily work with Hantavirus a BSL3 and isolation of viruses from the Brazilian samples. 4. Training and research opportunities for. Paraguayan scientists at the BSL3 facility in Riberao Preto. The specific aims of the research and capacity building include: Aim 1: To characterize the temporal dynamics of rodent population changes at selected sites in Brazil; Aim 2. To isolate Hantaviruses from the rodents collected in Aim 1 as well as to characterize their prevalence in rodents; Aim 3: To model the relationship between landscape and hantavirus occurrence in human cases in Brazil. Importantly, the objectives reached in aims 1 and 2 will permit analyses of the human infections in further depth and this information will be added to the modeling in Aim 3. Currently, in Latin America, the vast majority of the Hantaviruses that have been identified, have not been isolated. Hence, physicians and public health workers do not know to what virus their patient was exposed. In Latin America this is an important part of the clinical picture because of the presence of numerous strains of Hantavirus circulating in close or overlapping proximity. To truly understand the impact of the virus on human health, further diagnosis of the patient for the virus strain through neutralization assays will be valuable. As in the US, Brazil is building BSL3 facilities that can accommodate this work. Isolation of the viruses and the neutralization test requires working with live virus at BSL3. A major effort of this grant will be to transfer the technology to build the BSL3 capacity.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Colleen B Jonsson其他文献
Colleen B Jonsson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Colleen B Jonsson', 18)}}的其他基金
Antiviral & Antimicrobial Countermeasures Discovery and Development Core
抗病毒物质
- 批准号:
10793955 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery
增强 UTHSC RBL 设施的弹性、生物安全和对策发现
- 批准号:
10793951 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
Center of Excellence for Encephalitic Alphavirus Therapeutics
脑炎甲病毒治疗卓越中心
- 批准号:
10631703 - 财政年份:2022
- 资助金额:
$ 3.47万 - 项目类别:
UTHSC Regional Biocontainment Laboratory: Upgrade of Facility and Building System
UTHSC 区域生物防护实验室:设施和建筑系统升级
- 批准号:
10393982 - 财政年份:2021
- 资助金额:
$ 3.47万 - 项目类别:
UTHSC RBL Administrative Supplement For Antiviral Discovery & Development
UTHSC RBL 抗病毒药物发现行政补充
- 批准号:
10636200 - 财政年份:2021
- 资助金额:
$ 3.47万 - 项目类别:
Center of Excellence for Encephalitic Alphavirus Therapeutics
脑炎甲病毒治疗卓越中心
- 批准号:
10116260 - 财政年份:2019
- 资助金额:
$ 3.47万 - 项目类别:
Center of Excellence for Encephalitic Alphavirus Therapeutics
脑炎甲病毒治疗卓越中心
- 批准号:
10563173 - 财政年份:2019
- 资助金额:
$ 3.47万 - 项目类别:
Center of Excellence for Encephalitic Alphavirus Therapeutics
脑炎甲病毒治疗卓越中心
- 批准号:
10359711 - 财政年份:2019
- 资助金额:
$ 3.47万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Harnessing iron acquisition to hinder enterobacterial pathogenesis
利用铁的获取来阻碍肠细菌的发病机制
- 批准号:
10651432 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
Ion Mobility Spectrometry- quadrupole Time-of-Flight (IMS-qToF) Mass Spectrometer
离子淌度光谱仪 - 四极杆飞行时间 (IMS-qToF) 质谱仪
- 批准号:
10630627 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
IgE-suppressing small molecule compound Xanthopurpurin analog for multiple food allergies
抑制 IgE 的小分子化合物黄紫嘌呤类似物,用于治疗多种食物过敏
- 批准号:
10761370 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
Toxicology and Efficacy Studies of Intrathecal VersaMab-101 for spinal cord injury treatment
鞘内注射 VersaMab-101 治疗脊髓损伤的毒理学和疗效研究
- 批准号:
10697262 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
Discovery and validation of biomarkers of autoimmunity in Alzheimer's Disease.
阿尔茨海默病自身免疫生物标志物的发现和验证。
- 批准号:
10589569 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别: